SOURCE: digiMedical Solutions, Inc.

February 21, 2008 11:18 ET

digiMedical Solutions, Inc.™ Signs Contract With Christopher L. Wey, M.D., of Neuroscience and Spine Associates in Naples, Florida to Support $10 Million 2008 Revenue Goal

COLLEYVILLE, TX--(Marketwire - February 21, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) announced today that the Company has signed a contract with Christopher L. Wey, M.D, of Neuroscience and Spine Associates in Naples, Florida, to implement the digiRX system and digiReauth call center services. The system and services will take over the prescription reauthorization processing and refill management service for Dr. Wey's office. Separately, digiMedical recently announced increasing the sales team in the Naples and Fort Myers, Florida, markets to increase the Company's regional footprint and support the Company's $10 million 2008 revenue goal.

Dr. Christopher L. Wey stated, "The digiReauth system will increase our office efficiency by taking over our inbound prescription re-authorization and refill calls allowing our staff to focus on in-office patient care, while still maintaining a high level of customer service to patients needing re-authorized prescriptions. We are also very pleased with the high level of digital security and readability the system lends to prescription processing."

David W. Lee, Chief Executive Officer and Director for digiMedical Solutions, commented, "digiReauth's digital prescription reauthorization process and supporting customer service call center has proved to be a great support to our doctors. We are pleased to be able to provide these services to Dr. Wey at his clinic and look forward to expanding our services with his clinic and other doctors in the region as we ramp up our sales expansion in the area."

digiMedical Solutions, a Microsoft Partner, with operations in Texas and Florida, has built its own suite of proprietary software to handle prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now digiAccounting and the Company owns and operates five pharmacies throughout Texas and Florida.

To be added to digiMedical's corporate e-mail list for shareholders and interested investors, please send an e-mail to ir@digimedical.com.

About Neuroscience & Spine Associates (www.neurosurgeon.com)

Neuroscience & Spine Associates (NASA) employs Southwest Florida's leading practitioners in neurology, neurosurgery, rehabilitation and diagnostics. The on-staff specialists have combined their expertise to provide the highest quality, most technologically advanced patient care available from a single medical clinic. Their board certified physicians and professional staff are dedicated specialists in their field. Areas of service include:

--  MRI Center
--  Headache Center
--  Spine Care and Rehabilitation
--  Pain Management
--  Dementia
--  Balance/Dizziness
--  Nerve Disorders
--  Neurosurgery
    

About digiMedical Solutions, Inc.™

digiMedical Solutions, Inc.™ (http://www.digimedical.com/) is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless base d-prescription technology to doctors, acquisition of independent pharmacy chains and the sale of certain territories to "market partners" licensed to exploit the digiMedical Solutions™ model. digiMedical Solutions, Inc.™ currently owns and operates five (5) pharmacies located in Texas and Florida. digiMedical Solutions™' unique business model brings doctor, patients and pharmacies into next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information